Report Detail

Request for Sample of this report

Pharma & Healthcare Global Radiology Drug Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4746151
    • |
  • 05 October, 2026
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Radiology Drug Therapy market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Radiology Drug Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radiology Drug Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Radiology Drug Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Radiology Drug Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Radiology Drug Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiology Drug Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiology Drug Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Lantheus Holdings, Inc., Curium Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Radiology Drug Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oncology
Cardiology
Others
Market segment by Application
Hospitals
Academic & Research Institutes
Others
Market segment by players, this report covers
Nihon Medi-Physics
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
GE Healthcare
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Curium Pharma
Bayer AG
Clarity Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Radiology Drug Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radiology Drug Therapy, with revenue, gross margin, and global market share of Radiology Drug Therapy from 2021 to 2026.
Chapter 3, the Radiology Drug Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Radiology Drug Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radiology Drug Therapy.
Chapter 13, to describe Radiology Drug Therapy research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Radiology Drug Therapy by Type
    • 1.3.1 Overview: Global Radiology Drug Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Radiology Drug Therapy Consumption Value Market Share by Type in 2025
    • 1.3.3 Oncology
    • 1.3.4 Cardiology
    • 1.3.5 Others
  • 1.4 Global Radiology Drug Therapy Market by Application
    • 1.4.1 Overview: Global Radiology Drug Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Academic & Research Institutes
    • 1.4.4 Others
  • 1.5 Global Radiology Drug Therapy Market Size & Forecast
  • 1.6 Global Radiology Drug Therapy Market Size and Forecast by Region
    • 1.6.1 Global Radiology Drug Therapy Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Radiology Drug Therapy Market Size by Region, (2021-2032)
    • 1.6.3 North America Radiology Drug Therapy Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Radiology Drug Therapy Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Radiology Drug Therapy Market Size and Prospect (2021-2032)
    • 1.6.6 South America Radiology Drug Therapy Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Radiology Drug Therapy Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Nihon Medi-Physics
    • 2.1.1 Nihon Medi-Physics Details
    • 2.1.2 Nihon Medi-Physics Major Business
    • 2.1.3 Nihon Medi-Physics Radiology Drug Therapy Product and Solutions
    • 2.1.4 Nihon Medi-Physics Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Nihon Medi-Physics Recent Developments and Future Plans
  • 2.2 ITM Isotopen Technologien München AG
    • 2.2.1 ITM Isotopen Technologien München AG Details
    • 2.2.2 ITM Isotopen Technologien München AG Major Business
    • 2.2.3 ITM Isotopen Technologien München AG Radiology Drug Therapy Product and Solutions
    • 2.2.4 ITM Isotopen Technologien München AG Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ITM Isotopen Technologien München AG Recent Developments and Future Plans
  • 2.3 Advanced Accelerator Applications
    • 2.3.1 Advanced Accelerator Applications Details
    • 2.3.2 Advanced Accelerator Applications Major Business
    • 2.3.3 Advanced Accelerator Applications Radiology Drug Therapy Product and Solutions
    • 2.3.4 Advanced Accelerator Applications Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Advanced Accelerator Applications Recent Developments and Future Plans
  • 2.4 Telix Pharmaceuticals
    • 2.4.1 Telix Pharmaceuticals Details
    • 2.4.2 Telix Pharmaceuticals Major Business
    • 2.4.3 Telix Pharmaceuticals Radiology Drug Therapy Product and Solutions
    • 2.4.4 Telix Pharmaceuticals Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Telix Pharmaceuticals Recent Developments and Future Plans
  • 2.5 GE Healthcare
    • 2.5.1 GE Healthcare Details
    • 2.5.2 GE Healthcare Major Business
    • 2.5.3 GE Healthcare Radiology Drug Therapy Product and Solutions
    • 2.5.4 GE Healthcare Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 GE Healthcare Recent Developments and Future Plans
  • 2.6 Theragnostics Ltd.
    • 2.6.1 Theragnostics Ltd. Details
    • 2.6.2 Theragnostics Ltd. Major Business
    • 2.6.3 Theragnostics Ltd. Radiology Drug Therapy Product and Solutions
    • 2.6.4 Theragnostics Ltd. Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Theragnostics Ltd. Recent Developments and Future Plans
  • 2.7 NuView Life Sciences
    • 2.7.1 NuView Life Sciences Details
    • 2.7.2 NuView Life Sciences Major Business
    • 2.7.3 NuView Life Sciences Radiology Drug Therapy Product and Solutions
    • 2.7.4 NuView Life Sciences Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 NuView Life Sciences Recent Developments and Future Plans
  • 2.8 Jubilant Pharma Limited
    • 2.8.1 Jubilant Pharma Limited Details
    • 2.8.2 Jubilant Pharma Limited Major Business
    • 2.8.3 Jubilant Pharma Limited Radiology Drug Therapy Product and Solutions
    • 2.8.4 Jubilant Pharma Limited Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Jubilant Pharma Limited Recent Developments and Future Plans
  • 2.9 Lantheus Holdings, Inc.
    • 2.9.1 Lantheus Holdings, Inc. Details
    • 2.9.2 Lantheus Holdings, Inc. Major Business
    • 2.9.3 Lantheus Holdings, Inc. Radiology Drug Therapy Product and Solutions
    • 2.9.4 Lantheus Holdings, Inc. Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Lantheus Holdings, Inc. Recent Developments and Future Plans
  • 2.10 Curium Pharma
    • 2.10.1 Curium Pharma Details
    • 2.10.2 Curium Pharma Major Business
    • 2.10.3 Curium Pharma Radiology Drug Therapy Product and Solutions
    • 2.10.4 Curium Pharma Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Curium Pharma Recent Developments and Future Plans
  • 2.11 Bayer AG
    • 2.11.1 Bayer AG Details
    • 2.11.2 Bayer AG Major Business
    • 2.11.3 Bayer AG Radiology Drug Therapy Product and Solutions
    • 2.11.4 Bayer AG Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Bayer AG Recent Developments and Future Plans
  • 2.12 Clarity Pharmaceuticals
    • 2.12.1 Clarity Pharmaceuticals Details
    • 2.12.2 Clarity Pharmaceuticals Major Business
    • 2.12.3 Clarity Pharmaceuticals Radiology Drug Therapy Product and Solutions
    • 2.12.4 Clarity Pharmaceuticals Radiology Drug Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Clarity Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Radiology Drug Therapy Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Radiology Drug Therapy by Company Revenue
    • 3.2.2 Top 3 Radiology Drug Therapy Players Market Share in 2025
    • 3.2.3 Top 6 Radiology Drug Therapy Players Market Share in 2025
  • 3.3 Radiology Drug Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 Radiology Drug Therapy Market: Region Footprint
    • 3.3.2 Radiology Drug Therapy Market: Company Product Type Footprint
    • 3.3.3 Radiology Drug Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Radiology Drug Therapy Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Radiology Drug Therapy Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Radiology Drug Therapy Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Radiology Drug Therapy Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Radiology Drug Therapy Consumption Value by Type (2021-2032)
  • 6.2 North America Radiology Drug Therapy Market Size by Application (2021-2032)
  • 6.3 North America Radiology Drug Therapy Market Size by Country
    • 6.3.1 North America Radiology Drug Therapy Consumption Value by Country (2021-2032)
    • 6.3.2 United States Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Radiology Drug Therapy Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Radiology Drug Therapy Consumption Value by Type (2021-2032)
  • 7.2 Europe Radiology Drug Therapy Consumption Value by Application (2021-2032)
  • 7.3 Europe Radiology Drug Therapy Market Size by Country
    • 7.3.1 Europe Radiology Drug Therapy Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 7.3.3 France Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Radiology Drug Therapy Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Radiology Drug Therapy Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Radiology Drug Therapy Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Radiology Drug Therapy Market Size by Region
    • 8.3.1 Asia-Pacific Radiology Drug Therapy Consumption Value by Region (2021-2032)
    • 8.3.2 China Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 8.3.5 India Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Radiology Drug Therapy Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Radiology Drug Therapy Consumption Value by Type (2021-2032)
  • 9.2 South America Radiology Drug Therapy Consumption Value by Application (2021-2032)
  • 9.3 South America Radiology Drug Therapy Market Size by Country
    • 9.3.1 South America Radiology Drug Therapy Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Radiology Drug Therapy Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Radiology Drug Therapy Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Radiology Drug Therapy Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Radiology Drug Therapy Market Size by Country
    • 10.3.1 Middle East & Africa Radiology Drug Therapy Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Radiology Drug Therapy Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Radiology Drug Therapy Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Radiology Drug Therapy Market Drivers
  • 11.2 Radiology Drug Therapy Market Restraints
  • 11.3 Radiology Drug Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Radiology Drug Therapy Industry Chain
  • 12.2 Radiology Drug Therapy Upstream Analysis
  • 12.3 Radiology Drug Therapy Midstream Analysis
  • 12.4 Radiology Drug Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Radiology Drug Therapy. Industry analysis & Market Report on Radiology Drug Therapy is a syndicated market report, published as Global Radiology Drug Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Radiology Drug Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo